艾迪克斯
IEX
235.55
-0.87
-0.37%
艾迪克斯
US · IEX
#1045 按市值排名
上市于 1970
235.55
-0.87
-0.37%
实时 - 追踪5344个代码 - 心跳于355秒前
· 2026-10-16 19:30
✦ 量化股权信号 计算方式说明
增持
- 最近一期（2026/Q3）披露持股的机构数量减少了3家。
- 机构持股总比例上升了0.4个百分点。
机构持股
- 机构持股比例
- 104.58% +0.37pp
- 机构数量
- 840 -3
- 数据截至
- 2026/Q3 较上一报告期
持股变动 vs 资金流向
方向分歧机构在上一报告期增持了股份，同时该股在最近20个交易日的主力资金呈净流出——两者方向出现分歧。
机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。
持股人类型
Mutual Fund83.43%
Hedge Fund12.45%
Public Company2.65%
Government Pension Fund1.82%
Private Company1.70%
Sovereign Wealth Fund1.30%
Corporate Pension Plan0.60%
Family Office/Trust0.25%
Insurance Company0.24%
主要股东 截至 2026-06-30
BlackRock
7.78% · 5.73M 股
Vanguard Capital Management, LLC
7.13% · 5.26M 股
Vanguard Portfolio Management, LLC
5.07% · 3.73M 股
State Street Global Advisors
4.50% · 3.32M 股
PRIMECAP Management Company
4.48% · 3.30M 股
Millennium Management LLC
3.21% · 2.37M 股
Eaton Vance Management
3.13% · 2.30M 股
Geode Capital Management, LLC
2.85% · 2.10M 股
Nordea Investment Management AB
2.50% · 1.84M 股
UBS Asset Management
2.16% · 1.59M 股
条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。
内部人持股
共追踪50份申报 · 33次买入 · 10次卖出
| 姓名 | 职务 | 持股比例 |
|---|---|---|
| Eric Ashleman | Chief Executive Officer | 0.08% |
| David Parry | Independent Director | 0.03% |
| Sean Gillen | Senior Vice President | 0.03% |
| Katrina Helmkamp | Independent Non-Executive Chairperson | 0.01% |
| Abhishek Khandelwal | Senior Vice President | 0.01% |
| Tara Tereso | Group Executive of Health & Science Technologies | 0.01% |
| Akhil Mahendra | Interim CFO & VP of Corporate Development | 0.01% |
| Livingston Satterthwaite | Independent Director | 0.01% |
| Lisa Anderson | Senior Vice President | 0.01% |
| Allison Lausas | Chief Accounting Officer & Interim CFO | 0.00% |
内部人交易 最近的 Form 4 申报记录
| 日期 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-09-15 | Tara Tereso | Group Executive of Health & Science Technologies | Sale to Issuer | -290 | $222.84 |
| 2026-09-15 | William Simmons | -- | Sale to Issuer | -218 | $222.84 |
| 2026-09-10 | Tara Tereso | Group Executive of Health & Science Technologies | Sale to Issuer | -138 | $221.46 |
| 2026-08-28 | Allison Lausas | Chief Accounting Officer & Interim CFO | Sale to Issuer | -645 | $230.28 |
| 2026-08-11 | Lisa Anderson | Senior Vice President | Derivative Exercise and Sale | -385 | $93.27–238.59 |
| 2026-05-10 | Eric Ashleman | Chief Executive Officer | Derivative Exercise and Sale | -15,385 | $93.27–215.81 |
| 2026-05-05 | Carl Christenson | Independent Director | Other Acquisition | +805 | -- |
| 2026-05-05 | Mark Buthman | Independent Director | Other Acquisition | +805 | -- |
| 2026-05-05 | Katrina Helmkamp | Independent Non-Executive Chairperson | Other Acquisition | +1,035 | -- |
| 2026-05-05 | Matthijs Glastra | Director | Other Acquisition | +805 | -- |
| 2026-05-05 | Mark Beck | Independent Director | Other Acquisition | +805 | -- |
| 2026-05-05 | Stephanie Disher | Director | Other Acquisition | +805 | -- |
| 2026-05-05 | Alejandro Quiroz Centeno | Independent Director | Other Acquisition | +805 | -- |
| 2026-05-05 | Lakecia Gunter | Independent Director | Other Acquisition | +805 | -- |
| 2026-05-05 | L. Watts-Stanfield | Independent Director | Other Acquisition | +805 | -- |
| 2026-03-03 | Roopa Unnikrishnan | Senior Vice President of Strategy & Corporate Development | Intent to Sell (Form 144) | -4,309 | $204.41 |
| 2026-02-22 | Tara Tereso | Group Executive of Health & Science Technologies | Sale to Issuer | -154 | $207.48 |
| 2026-02-21 | Eric Ashleman | Chief Executive Officer | Other Acquisition | +9,040 | -- |
| 2026-02-21 | Eric Ashleman | Chief Executive Officer | Other Derivative Acquisition | +38,165 | $207.48 |
| 2026-02-19 | Allison Lausas | Chief Accounting Officer & Interim CFO | Sale to Issuer | -179 | $207.86 |
Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。
报价时间 2026-10-16 19:30:05 · 仅供参考，不构成投资建议，也未考虑您的具体情况。
艾迪克斯 讨论区 0 条评论